Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > LUM-201
View:
Post by fossi_2002 on Dec 15, 2023 9:34am

LUM-201

Always working with half-truths and ignoring the competition, that is the method of Proph.

GHRYVELIN (previously Macimorelin Aeterna Zentaris) will soon be facing competition from Lumos Pharma with its product LUM 201.
A study by Globaldata quotes the following:
The launch of LUM-201 has the potential to increase treatment rates and treatment adherence among PEM-positive pediatric patients due to the more favorable oral administration route.

https://www.globaldata.com/store/report/growth-hormone-secretagogue-receptor-type-1-drugs-in-development-analysis/

https://www.fiercebiotech.com/biotech/lumos-stock-rockets-phase-2-results-bring-first-oral-growth-hormone-drug-one-step-closer



Comment by prophetoffactz on Dec 15, 2023 9:43am
I've been posting about a AEZS's diagnostic test for growth hormone deficiency and you post about a therapy for growth hormone deficiency? And you post the therapy(LUM-201) could increase treatment rates for growth hormone deficiency? How will people know they need to be treated for growth hormone deficiency? With AEZS's growth hormone deficiency test? Seems like better treatments for ...more  
Ceapro Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities